Publications of Udo Reichl
All genres
Journal Article (267)
2023
Journal Article
15 (9), 1872 (2023)
Broad-Spectrum Antiviral Activity of Influenza A Defective Interfering Particles against Respiratory Syncytial, Yellow Fever, and Zika Virus Replication In Vitro. Viruses
Journal Article
10, 1266431 (2023)
Cell-free N-glycosylation of peptides using synthetic lipid-linked hybrid and complex N-glycans. Frontiers in Molecular Biosciences 2022
Journal Article
106, pp. 4945 - 4961 (2022)
Cell-line screening and process development for a fusogenic oncolytic virus in small-scale suspension cultures. Applied Microbiology and Biotechnology
Journal Article
15, 125 (2022)
Adaptation of a microbial community to demand-oriented biological methanation. Biotechnology for Biofuels and Bioproducts
Journal Article
259, 104544 (2022)
Absolute quantification of viral proteins during single-round replication of MDCK suspension cells. Journal of Proteomics
Journal Article
23 (2), e202100361 (2022)
Cell‐free multi‐enzyme synthesis and purification of uridine diphosphate galactose. ChemBioChem
Journal Article
11 (22), 3634 (2022)
Human 3D Airway Tissue Models for Real-Time Microscopy: Visualizing Respiratory Virus Spreading. Cells
Journal Article
10 (2), 249 (2022)
High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor. Vaccines
Journal Article
12 (3), 239 (2022)
Impact of Influenza A Virus Infection on Growth and Metabolism of Suspension MDCK Cells Using a Dynamic Model. Metabolites
Journal Article
23 (16), 8841 (2022)
Discovering Biomarkers for Non-Alcoholic Steatohepatitis Patients with and without Hepatocellular Carcinoma Using Fecal Metaproteomics. International Journal of Molecular Sciences 2021
Journal Article
11 (5), 726 (2021)
Fecal Metaproteomics Reveals Reduced Gut Inflammation and Changed Microbial Metabolism Following Lifestyle-Induced Weight Loss. Biomolecules
Journal Article
118 (10), pp. 3996 - 4013 (2021)
Towards integrated production of an influenza A vaccine candidate with MDCK suspension cells. Biotechnology and Bioengineering
Journal Article
20 (20), 162 (2021)
Combining functional metagenomics and glycoanalytics to identify enzymes that facilitate structural characterization of sulfated N-glycans. Microbial Cell Factories
Journal Article
342, pp. 139 - 148 (2021)
Continuous purification of influenza A virus particles using pseudo-affinity membrane chromatography. Journal of Biotechnology
Journal Article
118 (12), pp. 4720 - 4734 (2021)
A high cell density perfusion process for Modified Vaccinia virus Ankara production: process integration with inline DNA digestion and cost analysis. Biotechnology and Bioengineering
Journal Article
16 (1), e2000024 (2021)
Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production. Biotechnology Journal
Journal Article
19 (1), 91 (2021)
Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles. BMC Biology
Journal Article
105, pp. 7251 - 7264 (2021)
Cell culture–based production of defective interfering influenza A virus particles in perfusion mode using an alternating tangential flow filtration system. Applied Microbiology and Biotechnology
Journal Article
105 (1), pp. 129 - 146 (2021)
OP7, a novel influenza A virus defective interfering particle: production, purification, and animal experiments demonstrating antiviral potential. Applied Microbiology and Biotechnology
Journal Article
13 (8), pp. 1981 - 1989 (2021)
Multi-enzyme cascades for the in vitro synthesis of guanosine diphosphate L-fucose. ChemCatChem